Linklaters advises EIC Fund on its participation in the Series B equity funding round of PASQAL

Linklaters has advised EIC Fund (European Innovation Council Fund) on its participation in the €100 million Series B equity funding round of PASQAL.

PASQAL, a leader in neutral atoms quantum computing, will use the proceeds of this fundraising to accelerate the company’s research and development efforts to build a 1,000-qubit quantum computer in the short term and fault-tolerant architectures in the long term. The EIC Fund has notably invested alongside Temasek, Wa'ed Ventures and Bpifrance, through its Large Venture Fund. Continuing investors include Quantonation, the Defense Innovation Fund, Daphni and Eni Next.

Established in June 2020, the EIC Fund is a breakthrough initiative of the European Commission to make direct equity and quasi-equity investments (between €500,000 and €15m) in European high impact and deep tech start-ups and scale ups. 

Since its creation, Linklaters has advised EIC Fund on more than twenty investments in European startups, including CorWave, Aledia, Sileane, Xenothera, Antofénol, Novolyze, XSun, Rosi, Minuendo, Hiber, EpiEndo Pharmaceuticals, NIL Technology, Trisol Medical et Kahun Medical.

The Linklaters team in Paris was led by Corporate M&A counsel Mehdi Boumedine and associate Yasmine Sadik.